Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical losartan for corneal scarring
IRCT20250501065555N1Phase 2Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of losartan in corneal fibrosis, sponsored by Semnan University of Medical Sciences. Primary endpoints: Best corrected visual acuity, Intraocular pressure and 1 more. Started Jun 2025; status: completed.
02
Drugs
losartan
03
Conditions
corneal fibrosis
Beyond the preview
Go deeper on IRCT20250501065555N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250501065555N1.